目录肽产品
CRFS-003A
Astressin
DPhe-His-Leu-Leu-Arg-Glu-Val-Leu-Glu-Nle-Ala-Arg-Ala-Glu-Gln-Leu-Ala-Gln-cyclo(Glu-Ala-His-Lys)-Asn-Arg-Lys-Leu-Nle-Glu-Ile-Ile-NH2
DPhe-His-Leu-Leu-Arg-Glu-Val-Leu-Glu-Nle-Ala-Arg-Ala-Glu-Gln-Leu-Ala-Gln-cyclo(Glu-Ala-His-Lys)-Asn-Arg-Lys-Leu-Nle-Glu-Ile-Ile-NH2
Size：0.5
P1(RMB)：582
MW：3563.2
One letter sequence：fHLLREVLE-Nle-ARAEQLAQ-cyclo(EAHK)NRKL-Nle-EII-NH2
Molecular Formula：C161H269N49O42
Description：A new CRF antagonist (cyclo(30/33) that, when injected into the CSF at low doses (1-10ug), results in antagonistic action against CRF and stress-related alterations of gastrointestinal motor function, without an intrinsic effect in these in vivo systems.
Literature Reference：V. Martinez et al., J. Pharmacol. Exp. Ther., 280(2), 754 (1997)
Cas：
P1(RMB)：582
MW：3563.2
One letter sequence：fHLLREVLE-Nle-ARAEQLAQ-cyclo(EAHK)NRKL-Nle-EII-NH2
Molecular Formula：C161H269N49O42
Description：A new CRF antagonist (cyclo(30/33) that, when injected into the CSF at low doses (1-10ug), results in antagonistic action against CRF and stress-related alterations of gastrointestinal motor function, without an intrinsic effect in these in vivo systems.
Literature Reference：V. Martinez et al., J. Pharmacol. Exp. Ther., 280(2), 754 (1997)
Cas：
